Enovis Corporation (ENOV) vs Tandem Diabetes Care, Inc. (TNDM)

Enovis Corporation and Tandem Diabetes Care, Inc. are both Medical Devices companies. Enovis Corporation and Tandem Diabetes Care, Inc. are of similar size ($1.1B and $1.1B). Enovis Corporation grew revenue faster over the last twelve months: 4.89% against 3.96%. Tandem Diabetes Care, Inc. has the higher net margin (−6.08% vs −48.0%) and the higher return on invested capital (−10.3% vs −23.6%). Across the 18 metrics below, Enovis Corporation leads on 9 and Tandem Diabetes Care, Inc. on 9.

Valuation

Metric ENOV TNDM Medical Devices median
P/E n/m n/m 22.18
P/S 0.46 1.04 2.70
P/B 0.72 8.32 2.46
Price to free cash flow 16.70 n/m 22.53
EV/EBITDA 7.56 n/m 11.78
EV/Sales 1.02 1.18 2.38
Earnings yield (104.33%) (5.92%) (8.22%)
Free cash flow yield 5.99% (8.83%) (7.80%)

Profitability

Metric ENOV TNDM Medical Devices median
Gross margin 61.09% 56.01% 56.01%
Operating margin (45.14%) (4.40%) (15.03%)
Net margin (47.97%) (6.08%) (20.40%)
Free cash flow margin 2.77% (2.56%) (7.24%)
Return on equity (54.27%) (48.03%) (15.32%)
Return on assets (25.07%) (6.24%) (19.72%)
Return on invested capital (23.55%) (10.33%) (10.33%)

Growth

Metric ENOV TNDM Medical Devices median
Revenue growth (TTM) 4.89% 3.96% 8.80%
EPS growth (last fiscal year) (38.98%) (106.80%) —
Revenue growth, 5-year CAGR 14.94% 15.26% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENOV TNDM Medical Devices median
Debt to equity 0.87 4.62 0.07
Current ratio 1.98 3.18 2.50
Net debt to EBITDA 5.73 (0.10) 0.49

Dividend

Metric ENOV TNDM Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric ENOV TNDM Medical Devices median
Market cap 1.05b 1.06b 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack